ACHV
Achieve Life Sciences, Inc.- Healthcare
- Biotechnology
- $668M market cap
Forecast run · Oct 29, 2026Upside rank 760 of 3,186
Model Signal
ForecastQ Daily Probabilities
39.0%
81.3%
22.0%
Analyst Consensus
Recommendation2.00/5 Buy
Last price$6.49
Price target$15.25
Implied move+135.0%
Analysts6
ForecastQ Portfolios
Company Profile
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.